Molgramostim
- Generic Name
- Molgramostim
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 99283-10-0
- Unique Ingredient Identifier
- B321AL142J
- Background
Molgramostim has been used in trials studying the treatment of Bronchiectasis, Cystic Fibrosis, Pulmonary Alveolar Proteinosis, Acute Respiratory Distress Syndrome, and Autoimmune Pulmonary Alveolar Proteinosis.
- Associated Conditions
- -
- Associated Therapies
- -
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
- Conditions
- Interventions
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Savara Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT06431776
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites
- Conditions
- Interventions
- First Posted Date
- 2022-08-15
- Last Posted Date
- 2022-08-15
- Lead Sponsor
- Second Affiliated Hospital of Soochow University
- Target Recruit Count
- 40
- Registration Number
- NCT05501340
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
- Conditions
- Interventions
- First Posted Date
- 2020-09-10
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Savara Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT04544293
- Locations
- 🇺🇸
University Of Arkansas For Medical Services, Little Rock, Arkansas, United States
🇺🇸UCLA David Geffen School of Medicine, Los Angeles, California, United States
🇺🇸National Jewish Health, Denver, Colorado, United States
Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis
- First Posted Date
- 2018-03-29
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Savara Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03482752
- Locations
- 🇩🇰
Dept. Of Respiratory Diseases & Allergy, Ã…rhus, Denmark
🇫🇷CHU Rennes Hospital Pontchaillou, Service de Pneumologie, Rennes, France
🇩🇪Ruhrlandklinik Essen Westdeutsches Lungenzentrum am Universitätsklinikum Essen GmbH, Essen, Germany
Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients
- Conditions
- Interventions
- First Posted Date
- 2017-05-24
- Last Posted Date
- 2022-03-24
- Lead Sponsor
- Beijing 302 Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT03164889
- Locations
- 🇨🇳
302 Military Hospital, Beijing, Beijing, China
Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis
- Conditions
- Interventions
- First Posted Date
- 2016-03-08
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Savara Inc.
- Target Recruit Count
- 139
- Registration Number
- NCT02702180
- Locations
- 🇯🇵
Tohoku University Hospital, Sendai, Japan
🇺🇸University of Florida, Gainesville, Florida, United States
🇮🇱Rabin Medical Center, Petaẖ Tiqwa, Israel
Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
- Conditions
- Interventions
- First Posted Date
- 2015-06-11
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Savara Inc.
- Target Recruit Count
- 42
- Registration Number
- NCT02468908
- Locations
- 🇬🇧
Celerion, Belfast, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.